feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs",https://benzinga.com/general/biotech/21/06/21623136/the-daily-biotech-pulse-orphazyme-falters-at-fda-athiras-ceo-placed-on-temporary-leave-5-ipos,https://j.mp/3q59RGz
